Abbott touts global launch of 1st-of-its-kind bioresorbable drug-eluting stent
Abbott launches the "world's 1st drug-eluting bioresorbable vascular scaffold" in more than 30 countries across Europe, parts of Asia Pacific and Latin America.
Absorb, which won CE Mark approval in the European Union in January 2011, is now available across Europe and in parts of Asia Pacific and Latin America, the company announced yesterday. The healthcare giant had stated previously that it would launch commercially by the end of 2012.
Abbott consultant and Netherlands cardiologist Dr. Patrick Serruys waxed poetic about the potential for a fully resorbable stent system.